Meet ApplyKite Twin, the application assistant that learns with you

Meet your Twin, it learns with you

Your Twin learns with you

Launch week codes:30% off annual Pro20% off monthly Pro

Ends in00h00m00s

Stefania Tacconelli

Associate professor

University of Chieti-Pescara

Italy

Research Interests

Explore related searches

Professors in Italy Professors in Immunology Immunology professors in Italy

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (13)

Angel Lanas

SPAIN

View details

Paola Patrignani

ITALY

View details

Jie Yang

Group Leader

University of Oxford

UNITED KINGDOM

View details

Corrado Pedrazzani

University of Verona

ITALY

View details

Enrico Lugli

Principal Investigator

IRCCS Humanitas Research Hospital

ITALY

View details

Helena Idborg

Karolinska Institutet

SWEDEN

View details

Maurizio Ronci

Assistant Professor

University “G. d’Annunzio” of Chieti-Pescara

ITALY

View details

Ilaria Lampronti

Associate Professor

University of Ferrara

ITALY

View details

David Adams

Senior Group Leader (and Interim Programme Head)

Wellcome Sanger Institute

UNITED KINGDOM

View details

Simone Marcone

Trinity College Dublin

IRELAND

View details

Federica Blua

University of Turin

ITALY

View details

Angelo CICHELLI

FULL PROF

University of Chieti-Pescara

ITALY

View details

Rosa AMOROSO

University of Chieti-Pescara

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Stefania Tacconelli

Research Interests

Explore related searches

Articles (15)

Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity

GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models.

Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-<i>b</i>]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.

Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies.

Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin.

New antiplatelet approach: inhibiting Pim kinase to reduce constitutive surface expression of thromboxane A<sub>2</sub> receptor.

Protective Effect of Caffeine and Chlorogenic Acids of Coffee in Liver Disease

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα

Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention.

The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing.

Platelets and extracellular vesicles in disease promotion via cellular cross-talk and eicosanoid biosynthesis.

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action.

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients

Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells

Cyclooxygenases and platelet functions.

Collaborators (13)

Angel Lanas

Paola Patrignani

Jie Yang

Corrado Pedrazzani

Enrico Lugli

Helena Idborg

Maurizio Ronci

Ilaria Lampronti

David Adams

Simone Marcone

Federica Blua

Angelo CICHELLI

Rosa AMOROSO

Make your next move.

Stefania Tacconelli

Research Interests

Explore related searches

Articles (15)

Aspirin prevents metastasis by limiting platelet TXA2 suppression of T cell immunity

GY971 mitigates inflammation by reducing neutrophil recruitment in cystic fibrosis Ex Vivo and In Vivo models.

Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-&lt;i&gt;b&lt;/i&gt;]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.

Janus kinase inhibitors enhance prostanoid biosynthesis in human whole blood in vitro: implications for cardiovascular side effects and prevention strategies.

Evaluating plasma vesicle signatures in chronic coronary artery disease patients for tailored dual therapy with low-dose rivaroxaban and aspirin.

New antiplatelet approach: inhibiting Pim kinase to reduce constitutive surface expression of thromboxane A<sub>2</sub> receptor.

Protective Effect of Caffeine and Chlorogenic Acids of Coffee in Liver Disease

A sulfonimide derivative of bezafibrate as a dual inhibitor of cyclooxygenase-2 and PPARα

Platelets as crucial players in the dynamic interplay of inflammation, immunity, and cancer: unveiling new strategies for cancer prevention.

The future of pharmacology and therapeutics of the arachidonic acid cascade in the next decade: Innovative advancements in drug repurposing.

Platelets and extracellular vesicles in disease promotion via cellular cross-talk and eicosanoid biosynthesis.

Optimizing aspirin dose for colorectal cancer patients through deep phenotyping using novel biomarkers of drug action.

Biomarkers of Response to Low-Dose Aspirin in Familial Adenomatous Polyposis Patients

Tumor-Educated Platelet Extracellular Vesicles: Proteomic Profiling and Crosstalk with Colorectal Cancer Cells

Cyclooxygenases and platelet functions.

Collaborators (13)

Angel Lanas

Paola Patrignani

Jie Yang

Corrado Pedrazzani

Enrico Lugli

Helena Idborg

Maurizio Ronci

Ilaria Lampronti

David Adams

Simone Marcone

Federica Blua

Angelo CICHELLI

Rosa AMOROSO

Make your next move.

Exploiting the 2-(1,3,4,9-tetrahydropyrano[3,4-<i>b</i>]indol-1-yl)acetic Acid Scaffold to Generate COXTRANs: A New Class of Dual Cyclooxygenase Inhibitors-Thromboxane Receptor Antagonists.